Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
After a Covid-hit FY21 (when the IPM grew by only 2.2 per cent), the market posted a growth of 14.7 per cent in FY22, on a low base
Proposals to be discussed at Hyderabad conclave include having a centralised drug registration system under CDSCO
The UCPMP is voluntary and there is no legal penalty for violating the code
The government further added that it is working on providing statutory backing to the UCPMP code and "it is a time-consuming process, which cannot be completed in haste"
Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers
It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days
The US would continue to remain an important geography, but the firm says it hopes to double its revenues from China and grow revenues five-fold in Brazil in the next five years
Cadila Healthcare Chairman Pankaj Patel said the market can grow when there is overall growth
New launches, power brands, digital initiatives to keep it ahead of peers
With API supply, especially from China, facing some constraints because of lockdowns in several countries, demand from global clients had shot up for Indian players
Firm's consolidated total revenue for the quarter, however, fell marginally by 0.7% to stand at Rs 2,023 crore
India follows a market-based mechanism for determining ceiling prices of medicines that are a part of the National List of Essential Medicines (NLEM)
The Indian pharma market registered 14.5% YoY growth in November
The drop in growth for the month of October 2019 has been seen across the therapies.
The top 10 corporates contribute to 43% of the domestic pharma market
MedLife has seen 100 per cent year-on-year growth. It has built very unique assets that are not there with other players
Margins of biologics stood at 38% in Q1 as compared to 33% in the preceding quarter
Separation of Pfizer's off-patent business would be a tax-free spin-off
Being highly regulated, brands are wary about being too adventurous online
Price erosion has been in excess of 15 per cent last year and will perhaps be at similar levels this year due to sales channel consolidation, says Kaul